GFRAL Gene - GDNF Receptor Alpha Like

Introduction

GFRAL (GDNF Receptor Alpha Like) encodes the receptor for Glial Cell Line-Derived Neurotrophic Factor (GDNF) family ligands. Located on chromosome 6p12.1, GFRAL is the founding member of the GDNF receptor family and serves as the exclusive high-affinity receptor for GDNF and related ligands. ^{1GFRAL is the GDNF Receptor - NatureDOI 10.1038/nature14524Open reference}

GFRAL is a critical therapeutic target for neurodegenerative diseases, particularly Parkinson’s disease, as it mediates the neuroprotective effects of GDNF on dopaminergic neurons.^{1GFRAL is the GDNF Receptor - NatureDOI 10.1038/nature14524Open reference 2GFRAL Protein - UniProtOpen reference}

The protein encoded by GFRAL is GFRAL Protein.^{2GFRAL Protein - UniProtOpen reference 3GDNF Therapy in Parkinson's Disease - BrainDOI 10.1093/brain/awx108Open reference}

--- ^{4GFRAL in Neurodegeneration - Trends in Pharmacological Sciences2018 · DOI 10.1016/j.tips.2018.06.005Open reference}

Overview

flowchart TD
    GFRAL["GFRAL"] -->|"regulates"| BDNF_neurons["BDNF neurons"]
    GFRAL["GFRAL"] -->|"inhibits"| Als["Als"]
    GFRAL["GFRAL"] -->|"activates"| Als["Als"]
    GFRAL["GFRAL"] -->|"inhibits"| Cancer["Cancer"]
    GFRAL["GFRAL"] -->|"inhibits"| Tumor["Tumor"]
    GFRAL["GFRAL"] -->|"activates"| Ms["Ms"]
    GFRAL["GFRAL"] -->|"therapeutic target"| Obesity["Obesity"]
    GFRAL["GFRAL"] -->|"activates"| Inflammation["Inflammation"]
    GFRAL["GFRAL"] -->|"therapeutic target"| Cancer["Cancer"]
    GFRAL["GFRAL"] -->|"therapeutic target"| Als["Als"]
    GFRAL["GFRAL"] -->|"therapeutic target"| Ischemia["Ischemia"]
    GFRAL["GFRAL"] -->|"therapeutic target"| Myocardial_Infarction["Myocardial Infarction"]
    GFRAL["GFRAL"] -->|"therapeutic target"| Inflammation["Inflammation"]
    GFRAL["GFRAL"] -->|"therapeutic target"| Autoimmune["Autoimmune"]
    style GFRAL fill:#4fc3f7,stroke:#333,color:#000

GFRAL is a cell surface receptor that belongs to the GDNF receptor family (GFRalpha). Unlike other GFRalpha family members (GFRalpha1-4) which can bind multiple ligands, GFRAL shows high specificity for GDNF. It functions as a co-receptor, requiring association with the RET tyrosine kinase to transduce signals into the cell. ^{5RET Receptor Signaling - Cold Spring Harbor Perspectives in BiologyDOI 10.1101/cshperspect.a009050Open reference}

The discovery of GFRAL as the GDNF receptor resolved decades of research into GDNF signaling mechanisms and opened new therapeutic avenues for neurodegenerative disease treatment.

Gene Structure

Protein Structure and Function

Domain Architecture

GFRAL contains several structural features:

• N-terminal signal peptide: Targets protein to the secretory pathway

• ** extracellular domain**: Ligand binding

• Glycosylphosphatidylinositol (GPI) anchor: Membrane attachment

• C-terminal hydrophobic region: Membrane-spanning segment

Receptor Complex

GFRAL functions as part of a heteromeric receptor complex:

1. GFRAL: High-affinity ligand binding

2. RET: Tyrosine kinase transmembrane component

3. GDNF: Ligand that bridges GFRAL and RET

Signal Transduction

Upon ligand binding:

1. GDNF binds to GFRAL

2. GFRAL recruits and activates RET

3. RET autophosphorylates

4. Multiple downstream pathways are activated:

   • PI3K/Akt: Cell survival

   • RAS/ERK: Neurite outgrowth

   • PLCγ: Calcium signaling

Expression Pattern

Brain Expression

GFRAL is expressed in specific neuronal populations:

• Substantia nigra pars compacta: Dopaminergic neurons

• Ventral tegmental area: Mesolimbic dopamine neurons

• Striatum: Medium spiny neurons

• Motor neurons: Spinal cord

Peripheral Expression

• Enteric nervous system: Gut neurons

• Pancreas: Some endocrine cells

• Testis: Spermatogonia

Biological Functions

Neuronal Survival

GFRAL-mediated signaling promotes:

• Dopaminergic neuron survival: Critical for Parkinson’s therapy

• Motor neuron maintenance: Relevant to ALS

• Neurite outgrowth: Promotes axonal regeneration

• Synapse formation: Supports synaptic connectivity

Neuroplasticity

GDNF/GFRAL signaling affects:

• Dendritic arborization

• Synaptic plasticity

• Long-term potentiation

Regeneration

The GFRAL pathway supports:

• Axonal regeneration after injury

• Neuronal repair

• Functional recovery

Disease Associations

Parkinson’s Disease

GFRAL is a major therapeutic target in PD:

• Neuroprotection: GDNF preserves dopaminergic neurons

• Neurorestoration: Promotes function of surviving neurons

• Clinical trials: Multiple GDNF/GDNF mimetic trials

Amyotrophic Lateral Sclerosis (ALS)

• GFRAL expressed in motor neurons

• GDNF delivery trials in ALS

• Potential for motor neuron protection

Spinal Cord Injury

• GFRAL signaling promotes regeneration

• Potential for functional recovery

• Combined with rehabilitation

Stroke

• Neuroprotective effects

• Supports post-stroke recovery

• Angiogenesis promotion

Therapeutic Approaches

GDNF Delivery

Multiple delivery strategies:

• Protein infusion: Direct GDNF delivery to brain

• Gene therapy: AAV-mediated GFRAL/RET expression

• Cell therapy: GDNF-producing cell transplants

• Small molecules: GFRAL agonists

GFRAL-Targeting Drugs

• Monoclonal antibodies: Agonist antibodies

• Small molecule agonists: Non-peptide GFRAL activators

• Peptide mimetics: GDNF mimetics

Clinical Trials

Multiple clinical programs:

• Intraputaminal GDNF infusion: Shows promise in PD

• AAV2-GDNF: Gene therapy approaches

• Stem cell-derived neurons: Cell replacement therapy

Pathogenic Mechanisms

GFRAL Dysfunction

Reduced GFRAL signaling contributes to:

• Progressive dopaminergic neuron loss

• Impaired neuronal resilience

• Accelerated disease progression

Neuroinflammation

GDNF/GFRAL has anti-inflammatory effects:

• Reduces microglial activation

• Modulates cytokine production

• Protects against neuroinflammation

Protein Homeostasis

GFRAL signaling affects:

• Autophagy regulation

• Protein aggregate clearance

• ER stress responses

Research Models

Cellular Models

• Primary dopaminergic neuron cultures

• iPSC-derived neurons

• Motor neuron models

Animal Models

• Gfral knockout mice

• Gdnf knockout mice

• Parkinson’s disease models

• GFRAL humanized mice

Biomarkers and Diagnostics

Potential Biomarkers

• GFRAL expression levels

• Soluble GFRAL in CSF

• RET phosphorylation status

Patient Selection

• GFRAL expression as predictor

• RET status for treatment response

• Genetic variants affecting response

See Also

• GFRAL Protein

• ^{3GDNF Therapy in Parkinson's Disease - BrainDOI 10.1093/brain/awx108Open reference}(/entities/gdnf)

• Parkinson’s Disease

• Dopaminergic Neurons

• Neurotrophic Factors

• Substantia Nigra

External Links

• NCBI Gene: GFRAL

• UniProt: GFRAL

• OMIM: GFRAL

• GDNF Foundation

Background

The study of Gfral Gene Gdnf Receptor Alpha Like has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.